Related Experiment Video
Updated: Mar 24, 2026

Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
Caffeine Administration to Prevent Apnea in Very Premature Infants
Amir-Mohammad Armanian1, Ramin Iranpour1, Eiman Faghihian2
1Division of Neonatology, Department of Pediatrics, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Caffeine significantly reduced apnea incidence in high-risk premature infants. This intervention protected developing organs and brains in neonates weighing less than 1200 grams.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Pediatric Critical Care
Background:
- Apnea is common in premature infants, increasing with lower gestational age.
- Apnea can lead to significant damage to a neonate's developing brain and organs.
- Higher-risk neonates require interventions to prevent apnea-related complications.
Purpose of the Study:
- To investigate the preventive effects of caffeine on apnea incidence.
- To assess caffeine's efficacy in higher-risk neonates.
Main Methods:
- Single-center randomized control trial.
- Inclusion criteria: premature infants with birth weight ≤1200g.
- Caffeine group (n=26) received a loading dose (20 mg/kg) followed by maintenance (5 mg/kg daily). Control group (n=26) received no caffeine.
Main Results:
- Caffeine significantly reduced apnea incidence (p=0.001).
- Relative risk of apnea in the caffeine group was 0.250 (95% CI, 0.097-0.647).
- Only 15.4% of infants in the caffeine group experienced apnea versus 61.5% in the control group.
Conclusions:
- Preventive effects of caffeine on apnea are evident in very premature infants.
- Caffeine administration is effective in reducing apnea incidence in high-risk neonates.
- Early use of caffeine demonstrates significant protective benefits.
Background:
Apnea intervals frequently occur in premature infants. Periods of apnea occur more often with decreases in gestational age. Periods of apnea can cause damage to the infant's developing brain and other organs. This study was designed to investigate the preventive effects of caffeine on apnea incidence in higher-risk neonates.
Methods:
In this single-center randomized control trial study, premature infants with a birth weight of ≤1200 g were eligible for enrollment. Twenty-six infants were randomly assigned to receive 20 mg/kg caffeine, as the loading dose, which was followed by 5 mg/kg daily as the maintenance dose until the 10th day of life; these infants were compared with 26 infants in the control group. Primary outcomes were incidence of apnea, bradycardia, and cyanosis.
Results:
Fifty-two infants were enrolled (26 in the caffeine group and 26 in the control group). The preventive effect of caffeine on apnea was significant in these infants. The relative risk for incidence of apnea in preterm neonates with a birth weight of <1200 g was 0.250 (95% confidence interval, 0.097-0.647). Only four infants (15.4%) in the caffeine group developed apnea, compared with 16 (61.5%) in the control group (p = 0.001).
Conclusion:
It seems that preventative effects of caffeine on apnea become apparent by using the drug in very premature infants.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Drug Dosing: Infants and Children
Sleep Apnea
The condition is more prevalent among...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Drug Delivery: Enteral Route
Pharmacokinetics in Pediatric Patients: Drug Excretion

